Literature DB >> 19130059

Patterns of pulmonary function in smoking and nonsmoking patients with progressive systemic sclerosis.

Silvia A Quadrelli1, Luciana Molinari, Lorena M Ciallella, Martin Bosio, Alejandro Salvado.   

Abstract

Pulmonary involvement is a prominent feature in systemic sclerosis and a significant cause of morbidity and mortality. A restrictive ventilatory defect is typical and static lung volumes are usually reduced in patients with ILDs. The possibility of obstruction of small airways in progressive systemic sclerosis (SSc) has been suggested by widespread bronchiolectasis and peribronchial fibrosis noted at necropsy. A total of 46 patients with a diagnosis of SSc were retrospectively included in this study. Patients were classified according to their smoking status (never smokers, n = 34 and ex or current smokers, n = 12). Patients were also compared on the basis of the presence or not of an obstructive pattern on spirometry. The purpose of this study was to establish if SSc patients who are smokers have a different pattern of pulmonary function involvement. Our hypothesis was that smoking habit was not the only cause of air trapping and that the existence of small airway involvement secondary to SSc itself cannot be excluded.

Entities:  

Mesh:

Year:  2009        PMID: 19130059     DOI: 10.1007/s00296-008-0824-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  40 in total

Review 1.  Small airway involvement in interstitial lung disease: radiologic evidence.

Authors:  A G Wilcox
Journal:  Curr Opin Pulm Med       Date:  2000-09       Impact factor: 3.155

Review 2.  Lung involvement in systemic sclerosis.

Authors:  R M Silver; K S Miller
Journal:  Rheum Dis Clin North Am       Date:  1990-02       Impact factor: 2.670

3.  Pulmonary function in patients with systemic sclerosis.

Authors:  L Spagnolatti; M C Zoia; E Volpini; G Convertino; P Fulgoni; A Corsico; P Vitulo; I Cerveri
Journal:  Monaldi Arch Chest Dis       Date:  1997-02

Review 4.  The role of small airways in lung disease.

Authors:  R J Shaw; R Djukanovic; D P Tashkin; A B Millar; R M du Bois; P A Orr
Journal:  Respir Med       Date:  2002-02       Impact factor: 3.415

5.  Relationship between cutaneous and pulmonary involvement in systemic sclerosis.

Authors:  S Morelli; C Barbieri; A Sgreccia; L Ferrante; V Pittoni; F Conti; G Gualdi; E Polettini; O A Carlesimo; S Calvieri
Journal:  J Rheumatol       Date:  1997-01       Impact factor: 4.666

6.  D-penicillamine treatment of lung involvement in patients with systemic sclerosis (scleroderma).

Authors:  T A Medsger
Journal:  Arthritis Rheum       Date:  1987-07

7.  [Accuracy of spirometry in the diagnosis of pulmonary restriction].

Authors:  Silvia Quadrelli; Martín Bosio; Alejandro Salvado; Julio Chertcoff
Journal:  Medicina (B Aires)       Date:  2007       Impact factor: 0.653

8.  Chronic obstructive airway disease in patients with Sjögren's syndrome.

Authors:  H H Newball; S A Brahim
Journal:  Am Rev Respir Dis       Date:  1977-02

9.  Hypersensitivity pneumonitis: correlation of individual CT patterns with functional abnormalities.

Authors:  D M Hansell; A U Wells; S P Padley; N L Müller
Journal:  Radiology       Date:  1996-04       Impact factor: 11.105

10.  [Lung involvement in systemic sclerosis].

Authors:  Silvia Quadrelli; Lorena Ciallella; Antonio C Catalán Pellet; Luciana Molinari; Alejandro Salvado; Carolina Auad; Juan Carlos Spina
Journal:  Medicina (B Aires)       Date:  2007       Impact factor: 0.653

View more
  5 in total

1.  When there's smoke there's…scleroderma: evidence that patients with scleroderma should stop smoking.

Authors:  Andrew Leask
Journal:  J Cell Commun Signal       Date:  2011-01-08       Impact factor: 5.782

2.  Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study.

Authors:  Theodoros Dimitroulas; Georgios Giannakoulas; Hariklia Dimitroula; Tilemahos Sfetsios; Despina Parcharidou; Haralambos Karvounis; Loukas Settas
Journal:  Rheumatol Int       Date:  2010-07-25       Impact factor: 2.631

3.  Comparison of different measures of diffusing capacity for carbon monoxide (DLCO) in systemic sclerosis.

Authors:  Marie Hudson; Deborah Assayag; Melissa Caron; Benjamin D Fox; Andrew Hirsch; Russell Steele; Rebecca Gaudreau-Taillefer; Solène Tatibouet; Lawrence Rudski; Murray Baron
Journal:  Clin Rheumatol       Date:  2013-06-04       Impact factor: 2.980

4.  Smoking and pulmonary fibrosis: novel insights.

Authors:  Katerina D Samara; George Margaritopoulos; Athol U Wells; Nikolaos M Siafakas; Katerina M Antoniou
Journal:  Pulm Med       Date:  2011-06-15

Review 5.  Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis.

Authors:  Nicoletta Del Papa; Francesca Pignataro; Eleonora Zaccara; Wanda Maglione; Antonina Minniti
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.